Kuros Biosciences AG | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 13/03/2024 à 07:00, il y a 8 mois 10 jours

Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Kuros Biosciences AG reports significant growth in direct MagnetOs sales (163%) and total medical device sales (153%) in 2023. Positive EBITDA achieved. Plans for continued sales growth and profitability in 2024

Financial Results Sales Growth Kuros Biosciences AG MagnetOs Sales Medical Device Sales
BRÈVE

publiée le 08/03/2024 à 07:05, il y a 8 mois 15 jours

Kuros Biosciences dévoilera ses résultats financiers et ses développements pour l'exercice 2023

Résultats Annuels Kuros Biosciences Résultats Financiers 2023 Mise À Jour De L'entreprise Technologies De Greffe Osseuse
BRÈVE

publiée le 08/03/2024 à 07:05, il y a 8 mois 15 jours

Kuros Biosciences to Unveil 2023 Full Year Financial Results and Corporate Developments

Corporate Update Kuros Biosciences Bone Graft Technologies Annual Results Financial Results 2023
COMMUNIQUÉ DE PRESSE

publié le 08/03/2024 à 07:00, il y a 8 mois 15 jours

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Kuros Biosciences to report full-year financial results for 2023 and provide corporate update on March 13, 2024, with a conference call and webcast scheduled. Company overview and contact information included

Conference Call Corporate Update Kuros Biosciences Bone Graft Technologies Full-year Financial Results
COMMUNIQUÉ DE PRESSE

publié le 01/02/2024 à 07:00, il y a 9 mois 22 jours

Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences to present at the CG 2024 Musculoskeletal Conference in San Francisco, discussing its MagnetOs portfolio of products for spinal fusion. CEO Chris Fair and other executives will attend, with a replay available for 90 days. Kuros Biosciences is a leader in next generation bone graft technologies

Kuros Biosciences CG 2024 Musculoskeletal Conference MagnetOs Spinal Fusion Bone Graft Technologies
COMMUNIQUÉ DE PRESSE

publié le 31/01/2024 à 07:00, il y a 9 mois 23 jours

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Kuros Biosciences receives US FDA 510K clearance for MagnetOs Granules for interbody use and regulatory clearance in New Zealand. The company expands its international presence with an exclusive distribution agreement, extending the MagnetOs portfolio and bringing an advanced bone graft technology to the local medical community

FDA Clearance Kuros Biosciences MagnetOs Granules New Zealand Bone Graft
COMMUNIQUÉ DE PRESSE

publié le 12/10/2023 à 07:00, il y a 1 année 1 mois

Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
COMMUNIQUÉ DE PRESSE

publié le 09/08/2023 à 07:00, il y a 1 année 3 mois

Kuros Biosciences Reports Results for First Half 2023
COMMUNIQUÉ DE PRESSE

publié le 13/07/2023 à 19:29, il y a 1 année 4 mois

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
COMMUNIQUÉ DE PRESSE

publié le 08/05/2023 à 17:18, il y a 1 année 6 mois

Annual General Meeting of Kuros Biosciences approves all resolutions

Publié le 22/11/2024 à 17:45, il y a 1 jour 7 heures

IMMERSION : RFA 2023/2024
Publié le 22/11/2024 à 16:15, il y a 1 jour 9 heures

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 22/11/2024 à 14:35, il y a 1 jour 10 heures

Communiqué de presse Thales
Publié le 22/11/2024 à 14:35, il y a 1 jour 10 heures

Thales Press release
Publié le 21/11/2024 à 06:58, il y a 2 jours 18 heures

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

Voir tout LES ECHOS COMFI WIRE

Publié le 22/11/2024 à 23:55, il y a 1 jour 1 heure

Boron One Announces Early Warrant Exercise Incentive Program
Publié le 22/11/2024 à 23:30, il y a 1 jour 1 heure

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Publié le 22/11/2024 à 23:05, il y a 1 jour 2 heures

Kidoz Inc. Announces Results of 2024 AGM
Publié le 22/11/2024 à 23:05, il y a 1 jour 2 heures

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Publié le 22/11/2024 à 22:30, il y a 1 jour 2 heures

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

Voir tout ACCESSWIRE

Publié le 22/11/2024 à 18:14, il y a 1 jour 7 heures

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 18:00, il y a 1 jour 7 heures

Holding(s) in Company
Publié le 22/11/2024 à 17:53, il y a 1 jour 7 heures

Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 1 jour 8 heures

EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 1 jour 9 heures

Proposed cancellation of admission to trading

Voir tout EQS

News